StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna Consolidated total revenue by customer geography

Consolidated total revenue by customer geography ($M) ($M)

Moderna Consolidated total revenue by customer geography: $145M in Q2 2026, up 2.1% from a year earlier.

Latest, Q2 2026
145
Period ended Jun 30, 2026
Change on a year earlier
+2.1%
142 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
25
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-07-31) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Operations & Geographic Footnote.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConsolidated total revenue by customer geography ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026145+2.1%Form 10-Q (filed 2026-07-31) ↗
Q1 2026Mar 31, 2026389+260.2%Form 10-Q (filed 2026-05-01) ↗
Q4 2025Dec 31, 2025678-29.8%Form 10-K (filed 2026-02-20) ↗
Q3 2025Sep 30, 20251,016-45.4%Form 10-Q (filed 2025-11-06) ↗
Q2 2025Jun 30, 2025142-41.1%Form 10-Q (filed 2026-07-31) ↗
Q1 2025Mar 31, 2025108-35.3%Form 10-Q (filed 2026-05-01) ↗
Q4 2024Dec 31, 2024966-65.6%Form 10-K (filed 2026-02-20) ↗
Q3 2024Sep 30, 20241,862+1.7%Form 10-Q (filed 2025-11-06) ↗
Q2 2024Jun 30, 2024241-29.9%Form 10-Q (filed 2025-08-01) ↗
Q1 2024Mar 31, 2024167-91.0%Form 10-Q (filed 2025-05-01) ↗
Q4 2023Dec 31, 20232,811-44.7%Form 10-K (filed 2026-02-20) ↗
Q3 2023Sep 30, 20231,831-45.6%Form 10-Q (filed 2024-11-07) ↗
Q2 2023Jun 30, 2023344-92.8%Form 10-Q (filed 2024-08-01) ↗
Q1 2023Mar 31, 20231,862-69.3%Form 10-Q (filed 2024-05-02) ↗
Q4 2022Dec 31, 20225,084-29.5%Form 10-K (filed 2025-02-21) ↗
Q3 2022Sep 30, 20223,364-32.3%Form 10-Q (filed 2023-11-03) ↗

Breakdown

What makes up consolidated total revenue by customer geography

Cite this data

StockData. (2026). Moderna Consolidated total revenue by customer geography ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/rev-total-geo

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.